(Q41119615)

English

Galanthamine

scientific article published on July 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

Galanthamine (English)

1 reference

Europe PubMed Central

27 September 2017

author name string

B Fulton

1

1 reference

Europe PubMed Central

27 September 2017

P Benfield

2

1 reference

Europe PubMed Central

27 September 2017

publication date

1 July 1996

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

9

1 reference

Europe PubMed Central

27 September 2017

1

1 reference

Europe PubMed Central

27 September 2017

60-5; discussion 66-7

1 reference

Europe PubMed Central

27 September 2017

https://scigraph.springernature.com/pub.10.2165/00002512-199609010-00006

0 references

THA does not affect sleep or EEG spectral power in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of galanthamine hydrobromide after single subcutaneous and oral dosage in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-acting cholinesterase inhibitor reverses spatial memory deficits in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galanthamine, an acetylcholinesterase inhibitor: a time course of the effects on performance and neurochemical parameters in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of galanthamine (a long-acting anticholinesterase drug) in anaesthetized patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galanthamine treatment in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the cholinesterase inhibiting substance galanthamine on human EEG and visual evoked potentials

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/8818586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002512-199609010-00006

1 reference

Europe PubMed Central

27 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41119615&oldid=2094077954"